Sartorius Stedim Cellca, based near Ulm in southern Germany, purchased property of more than 6,000 square meters at Ulm’s Science Park III at Eselsberg to build a new laboratory and office complex. The new facility, which will approximately double the company’s space, is scheduled to be completed by the end of 2019.

“Our new site’s proximity to universities and research institutes in Ulm’s Scientific Park offers an excellent environment to promote our growing business for which we are also seeking additional highly qualified staff,“ said Hugo de Wit, managing director, Sartorius Stedim Cellca. “Besides the advantages offered by this research environment, its conveniently accessible location was also decisive for us. We need to be within easy reach of our international customers.”

Sartorius Stedim Cellca develops and markets platform technologies, such as cell lines and associated services, for customers in the biopharmaceutical industry. Since 2015, the company has been part of the biopharma supplier Sartorius Stedim Biotech and currently employs 80 people.